Gene · 3663
Papers4,211
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,181 to 1,200 of 4,211
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Role of Clinical Features and Serum Biomarkers in Identifying Patients with Incomplete Lupus Erythematosus at Higher Risk of Transitioning to Systemic Lupus Erythematosus: Current Perspectives. | J Inflamm Res | 2022 | 35210816 | PubTator, text mining | PubMed |
| Expression of Autoimmunity-Related Genes in Melanoma. | Cancers (Basel) | 2022 | 35205739 | PubTator, text mining | PubMed |
| Cytoplasmic and Nuclear Functions of cIAP1. | Biomolecules | 2022 | 35204822 | PubTator, text mining | PubMed |
| Therapeutic Options for Systemic Sclerosis: Current and Future Perspectives in Tackling Immune-Mediated Fibrosis. | Biomedicines | 2022 | 35203525 | PubTator, text mining | PubMed |
IL-23 production in human macrophages is regulated negatively by tumor necrosis factor α-induced protein 3 and positively by specificity protein 1 after stimulation of the toll-like receptor 7/8 signaling pathway. | Heliyon | 2022 | 35198762 | PubTator, text mining | PubMed |
| Protective immune trajectories in early viral containment of non-pneumonic SARS-CoV-2 infection. | Nat Commun | 2022 | 35197461 | PubTator, text mining | PubMed |
| Why do men have worse COVID-19-related outcomes? A systematic review and meta-analysis with sex adjusted for age. | Braz J Med Biol Res | 2022 | 35195196 | PubTator, text mining | PubMed |
| Protein O-GlcNAcylation Regulates Innate Immune Cell Function. | Front Immunol | 2022 | 35185892 | PubTator, text mining | PubMed |
| The Emerging Role of RNA Modifications in the Regulation of Antiviral Innate Immunity. | Front Microbiol | 2022 | 35185855 | PubTator, text mining | PubMed |
| Investigation of Molecular Iridium Fluorides IrFn (n=1-6): A Combined Matrix-Isolation and Quantum-Chemical Study. | Chemistry | 2022 | 35181951 | PubTator, text mining | PubMed |
| Overexpressed CMTM6 Improves Prognosis and Associated With Immune Infiltrates of Ovarian Cancer. | Front Mol Biosci | 2022 | 35174213 | PubTator, text mining | PubMed |
| New Insights Into the Epigenetic Regulation of Inflammatory Bowel Disease. | Front Pharmacol | 2022 | 35173618 | PubTator, text mining | PubMed |
| Human herpesvirus 6 infection as a trigger of multiple sclerosis: an update of recent literature. | BMC Neurol | 2022 | 35168545 | PubTator, text mining | PubMed |
| Established risk loci for systemic lupus erythematosus at NCF2, STAT4, TNPO3, IRF5 and ITGAM associate with distinct clinical manifestations: A Danish genome-wide association study. | Joint Bone Spine | 2022 | 35167971 | PubTator, text mining | PubMed |
| Current Status and Challenges of Human Induced Pluripotent Stem Cell-Derived Liver Models in Drug Discovery. | Cells | 2022 | 35159250 | PubTator, text mining | PubMed |
| Multistability in Macrophage Activation Pathways and Metabolic Implications. | Cells | 2022 | 35159214 | PubTator, text mining | PubMed |
| Expression of CTLA-4 and CD86 Antigens and Epstein-Barr Virus Reactivation in Chronic Lymphocytic Leukemia-Any Link with Known Prognostic Factors? | Cancers (Basel) | 2022 | 35158937 | PubTator, text mining | PubMed |
| A Pan-Cancer Analysis of the Oncogenic Role of Nuclear Transport Factor 2 in Human Cancers. | Front Oncol | 2022 | 35155261 | PubTator, text mining | PubMed |
| Systemic lupus erythematosus as a genetic disease. | Clin Immunol | 2022 | 35149194 | PubTator, text mining | PubMed |
| Pattern Recognition Receptor Signaling and Cytokine Networks in Microbial Defenses and Regulation of Intestinal Barriers: Implications for Inflammatory Bowel Disease. | Gastroenterology | 2022 | 35149024 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3663/papers?page=60